Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 23, 2017

DrugPatentWatch Database Preview

BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

Which patents cover Bretylium Tosylate In Dextrose 5% In Plastic Container, and when can generic versions of Bretylium Tosylate In Dextrose 5% In Plastic Container launch?

Bretylium Tosylate In Dextrose 5% In Plastic Container is a drug marketed by Hospira Inc, B Braun, and Baxter Hlthcare. and is included in three NDAs.

The generic ingredient in BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER is bretylium tosylate. There are three drug master file entries for this compound. Additional details are available on the bretylium tosylate profile page.

Summary for Tradename: BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER

Patents:0
Applicants:3
NDAs:3
Bulk Api Vendors: see list41
Clinical Trials: see list324
Drug Prices:see details
DailyMed Link:BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira Inc
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019008-002Apr 29, 1986DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019837-002Apr 12, 1989DISCNNoNo► Subscribe► Subscribe
B Braun
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019121-001Apr 29, 1986DISCNNoNo► Subscribe► Subscribe
Baxter Hlthcare
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019837-001Apr 12, 1989DISCNNoNo► Subscribe► Subscribe
Hospira Inc
BRETYLIUM TOSYLATE IN DEXTROSE 5% IN PLASTIC CONTAINER
bretylium tosylate
INJECTABLE;INJECTION019008-003Apr 29, 1986DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Predict branded drug patent expiration
  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot